Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fenichel, P.
Right arrow Articles by Harter, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fenichel, P.
Right arrow Articles by Harter, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 12, 2623-2628, Copyright © 1997 by Oxford University Press


ARTICLES

Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure

P Fenichel, C Sosset, P Barbarino-Monnier, B Gobert, S Hieronimus, MC Bene and M Harter
Service d'Endocrinologie et Reproduction, Centre Hospitalo- Universitaire, Nice, France.

Autoimmunity may be involved in idiopathic premature ovarian failure (POF). However, the frequency, physiopathology and potential reversibility of autoimmune oophoritis needs clarification. Using an ELISA against whole tissue homogenate as antigen, from human ovaries at different ages, positive circulating ovarian antibodies (AOA) were found in 59% of patients with primitive idiopathic POF (27/46); 20/27 were positive for IgG isotype, 9/27 for IgM and 8/27 for IgA. Specificity of AOA was examined (i) by comparison to different control groups; mean values of the three subclasses of immunoglobins were significantly higher in POF women than in normally cycling fertile young women (n = 23) and fertile young men (n = 17), in untreated Grave's disease (n = 35) or in women with positive antinuclear factor (n = 25); and (ii) by assessing possible cross-reaction; only six out of the 27 positive sera reacted with other tissues (thyroid, pancreas, adrenal), including four clinical polyendocrinopathies. Significance of AOA was explored (i) by comparison with postmenopausal women (n = 40) and older women (n = 15), who did not have enhanced ratios of AOA, thereby excluding a potential role of high FSH values; (ii) by analysing the factors time and surgery; no relation could be found either with the duration of amenorrhoea (6 months to 21 years) or with the history of an ovarian biopsy (12/47) in the absence of any associated pelvic surgery; and (iii) by screening for other immunological factors; familial or personal autoimmune disease (8/46), HLA DR3 (10/42), HLA DR4 (11/42), associated autoantibodies (thyroperoxidase, adrenal, beta islets, parathyroid, DNA, smooth muscles) (12/42). If one positive AOA isotype was present, a second immunological factor was found in 45% of cases. Spontaneous pregnancies during oestrogen therapy occurred in four cases, including three women with positive AOA. Circulating AOA detected by an ELISA may represent a practical and suitable marker for diagnosis of POF. Its use for prognosis and rational treatment needs further evaluation.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
E. S. Pires, P. P. Parte, P. K. Meherji, S. A. Khan, and V. V. Khole
Naturally Occurring Anti-albumin Antibodies Are Responsible for False Positivity in Diagnosis of Autoimmune Premature Ovarian Failure
J. Histochem. Cytochem., April 1, 2006; 54(4): 397 - 405.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
D. Goswami and G. S. Conway
Premature ovarian failure
Hum. Reprod. Update, July 1, 2005; 11(4): 391 - 410.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
T. Forges, P. Monnier-Barbarino, G.C. Faure, and M.C. Bene
Autoimmunity and antigenic targets in ovarian pathology
Hum. Reprod. Update, March 1, 2004; 10(2): 163 - 175.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.L. Luborsky, P. Meyer, M.F. Sowers, E.B. Gold, and N. Santoro
Premature menopause in a multi-ethnic population study of the menopause transition
Hum. Reprod., January 1, 2003; 18(1): 199 - 206.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Luborsky, B. Llanes, R. Roussev, and C. Coulam
Ovarian antibodies, FSH and inhibin B: independent markers associated with unexplained infertility
Hum. Reprod., May 1, 2000; 15(5): 1046 - 1051.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S.N. Kalantaridou, D.T. Braddock, N.J. Patronas, and L.M. Nelson
Treatment of autoimmune premature ovarian failure: Case report
Hum. Reprod., July 1, 1999; 14(7): 1777 - 1782.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
B. Ishizuka, Y. Kudo, A. Amemiya, H. Yamada, T. Matsuda, and T. Ogata
Anti-nuclear antibodies in patients with premature ovarian failure
Hum. Reprod., January 1, 1999; 14(1): 70 - 75.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.